Article Data

  • Views 541
  • Dowloads 136

Original Research

Open Access

Predictors of malignancy in endometrial polyps: a multi-institutional cohort study

  • P. Litta1,*,
  • J. Di Giuseppe2
  • L. Moriconi2
  • G. Delli Carpini2
  • M.G. Piermartiri2
  • A. Ciavattini2

1Department of Women’s and Children’s Health, Obstetrics and Gynecology Clinic, University of Padua, Padua

2Woman's Health Sciences Department, Università Politecnica delle Marche, Ancona (Italy)

DOI: 10.12892/ejgo26802014 Vol.35,Issue 4,July 2014 pp.382-386

Published: 10 July 2014

*Corresponding Author(s): P. Litta E-mail: pietro.litta@unipd.it

Abstract

Purpose of investigation: The risk of endometrial cancer in women with endometrial polyps (EPs) has been reported to vary between 0.3% and 4.8%. There is a lack of data about the management of asymptomatic women with incidental diagnosis of EPs. In the present study the authors correlated demographic and clinical characteristics with histopathological features of the EPs hysteroscopically removed. Materials and Methods: An observational multi-institutional cohort study was conducted from February 2010 to December 2012 to identify all the premenopausal and postmenopausal women consecutively undergoing hysteroscopic polypectomy. The data of women were reviewed and clinical features were related to histopathologic results. Results: The patients recruited were 813. The mean age was 52.5 years (range 22-87). The results showed a correlation between older age, high body mass index (BMI) and obesity, postmenopausal state, abnormal uterine bleeding (AUB), hypertension, and risk of malignant EPs. On multivariable analysis, the correlation remained only for age (OR 1.08, 95% CI 1.03 - 1.14) and AUB (OR 3.53, 95% CI 1.87 - 6.65). Conclusion: Older patients in postmenopausal status with AUB, a high BMI, and hypertension are at higher risk for premalignant and malignant polyps. In these patients a surgical approach should be used, consisting in hysteroscopical removing of the polyp.

Keywords

Endometrial polyps; Body mass index; Hypertension; Endometrial cancer; Hysteroscopic polypectomy.

Cite and Share

P. Litta,J. Di Giuseppe,L. Moriconi,G. Delli Carpini,M.G. Piermartiri,A. Ciavattini. Predictors of malignancy in endometrial polyps: a multi-institutional cohort study. European Journal of Gynaecological Oncology. 2014. 35(4);382-386.

References

[1] Litta P., Merlin F., Saccardi C., Pozzan C., Sacco G., Fracas M., et al.: “Role of hysteroscopy with endometrial biopsy to rule out endometrial cancer in postmenopausal women with abnormal uterine bleeding”. Maturitas, 2005, 50, 117.

[2] Rosai J., Ackerman L.V.: “Rosai and Ackerman’s Surgical Pathology”. 9th ed. Rosai J. (ed). St. Louis: Mosby, 2004, 3080.

[3] Costa-Paiva L., Godoy C.E. Jr., Antunes A. Jr., Caseiro J.D., Arthuso M., Pinto-Neto A.M.: “Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic

characteristics”. Menopause, 2011, 18, 1278.

[4] Dreisler E., Stampe Sorensen S., Ibsen P.H., Lose G.: “Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74years”. Ultrasound Obstet. Gynecol., 2009, 33, 102.

[5] Wethington S.L., Herzog T.J., Burke W.M., Sun X., Lerner J.P., Lewin S.N., et al.: “Risk and predictors of malignancy in women with endometrial polyps”. Ann. Surg. Oncol., 2011, 18, 3819.

[6] Ferrazzi E., Zupi E., Leone F.P., Savelli L., Omodei U., Moscarini M., et al.: “How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study”. Am. J. Obstet. Gynecol., 2009, 200, 235.

[7] Litta P., Bartolucci C., Saccardi C., Codroma A., Fabris A., Borgato S., et al.: “Atypical endometrial lesions: hysteroscopic resection as an alternative to hysterectomy: European Journal of Gynecology Oncology”. Eur. J. Gynaecol. Oncol., 2013, 34, 51.

[8] Machtinger R., Korach J., Padoa A., Fridman E., Zolti M., Segal J., et al.: “Transvaginal ultrasound and diagnostic hysteroscopy as a predictor of endometrial polyps: risk factors for premalignancy and malignancy”. Int. J. Gynecol. Cancer, 2005, 15, 325.

[9] Antunes A. Jr., Costa-Paiva L., Arthuso M., Costa J.V., Pinto-Neto A.M.: “Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy”. Maturitas, 2007, 57, 415.

[10] Fernández-Parra J., Rodríguez Oliver A., López Criado S., Parrilla Fernández F., Montoya Ventoso F.: “Hysteroscopic evaluation of endometrial polyps”. Int. J. Gynaecol. Obstet., 2006, 95, 144.

[11] Schmidt T., Breidenbach M., Nawroth F., Mallmann P., Beyer I.M., Fleisch M.C., et al.: “Hysteroscopy for asymptomatic postmenopausal women with sonographically thickened endometrium”. Maturitas, 2009, 62, 176.

[12] Ben-Arie A., Goldchmit C., Laviv Y., Levy R., Caspi B., Huszar M., et al.: “The malignant potential of endometrial polyps”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2004, 115, 206.

[13] Litta P., Fabris A.M., Breda E., Bartolucci C., Conte L., Saccardi C., et al.: “Laparoscopic surgical staging of endometrial cancer: does obesity influence feasibility and perioperative outcome?” Eur. J. Gynaecol. Oncol., 2013, 34, 231.

[14] Litta P., Saccardi C., Conte L., Florio P.: “Reverse hysterectomy: another technique for performing a laparoscopic hysterectomy”. J. Minim. Invasive Gynecol., 2013, 20, 631.

[15] Litta P., Cosmi E., Saccardi C., Esposito C., Rui R., Ambrosini G.: “Outpatient operative polypectomy using a 5 mm-hysteroscope without anaesthesia and/or analgesia: advantages and limits”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2008, 139, 210.

[16] Florio P., Filippeschi M., Imperatore A., Mereu L., Franchini M., Calzolari S., et al.: “The practicability and surgeons’ subjective experiences with vaginal danazol before an operative hysteroscopy”. Steroids, 2012, 77, 528.

[17] Colacurci N., De Franciscis P., Mollo A., Litta P., Perino A., Cobellis L., et al.: “Small-diameter hysteroscopy with Versapoint versus resectoscopy with a unipolar knife for the treatment of septate uterus: a prospective randomized study”. J. Minim. Invasive Gynecol., 2007, 14, 622.

[18] Florio P., Puzzutiello R., Filippeschi M., D’Onofrio P., Mereu L., Morelli R., et al.: “Low-dose spinal anesthesia with hyperbaric bupivacaine with intrathecal fentanyl for operative hysteroscopy: a case series study”. J. Minim. Invasive Gynecol., 2012, 19, 107.

[19] Litta P., Merlin F., Pozzan C., Nardelli G.B., Capobianco G., Dessole S., Ambrosini A.: “Transcervical endometrial resection in women with menorrhagia: long-term follow-up”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2006, 125, 99.

[20] Kurman R.J.: “Blaustein’s pathology of the female genital tract”. 5th ed. New York: Springer-Verlag, 2002.

[21] Baiocchi G., Manci N., Pazzaglia M., Giannone L., Burnelli L., Giannone E., et al.: “Malignancy in endometrial polyps: a 12-year experience”. Am. J. Obstet. Gynecol., 2009, 201, 462.

[22] Savelli L, De Iaco P, Santini D, Rosati F, Ghi T, Pignotti E, et al. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am. J. Obstet. Gynecol., 2003, 188, 927.

[23] Lee S.C., Kaunitz A.M., Sanchez-Ramos L., Rhatigan R.M.: “The oncogenic potential of endometrial polyps: a systematic review and meta-analysis”. Obstet. Gynecol., 2010, 116, 1197.

[24] Bettocchi S., Ceci O., Di Venere R., Pansini M.V., Pellegrino A., Marello F., et al.: “Advanced operative office hysteroscopy without anaesthesia: analysis of 501 cases treated with a 5 Fr. Bipolar electrode”. Hum. Reprod., 2002, 17, 2435.

[25] Wang J.H., Zhao J., Lin J.: “Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies”. J. Minim. Invasive Gynecol., 2010, 17, 53.

[26] Giordano G., Gnetti L., Merisio C., Melpignano M.: “Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps”. Maturitas, 2007, 20, 190.

[27] Ward K.K., Roncancio A.M., Shah N.R., Davis M.A., Saenz C.C., McHale M.T., Plaxe S.C.: “The risk of uterine malignancy is linearly associated with body mass index in a cohort of US women”. Am. J. Obstet. Gynecol., 2013, 209, 579.e1.

[28] Liberis V., Tsikouras P., Christos Z., Ammari A., Dislian V., Koutlaki N., et al.: “The contribution of hysteroscopy to the detection malignancy in symptomatic postmenopausal women”. Minim. Invasive Ther. Allied Technol., 2010, 19, 83.

[29] World Cancer Research Fund/American Institute for Cancer Research: “Food, Nutrition, Physical Activity, and Prevention of Cancer: a Global Perspective”. Washington DC: AIRC, 2007. Available at: http://www.dietandcancerreport.org/cancer_resource_center/downloads/Second_Expert_Report_full.pdf

[30] Crosbie E.J, Zwahlen M., Kitchener H.C., Egger M., Renehan A.G.: “Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis”. Cancer Epidemiol. Biomarkers Prev., 2010, 19, 3119.

[31] Tinelli R., Litta P., Meir Y., Surico D., Leo L., Fusco A., et al.: “Advantages of Laparoscopy Versus Laparotomy in Extremely Obese Women (BMI>35) with Early-stage Endometrial Cancer: A Multicenter Study”. Anticancer Res., 2014, 34, 2497.

[32] Daniele A., Ferrero A., Maggiorotto F., Perrini G., Volpi E., Sismondi P.: “Suspecting malignancy in endometrial polyps: value of hysteroscopy”. Tumori, 2013, 99, 204.

[33] DeWaay D.J., Syrop C.H., Nygaard I.E., Davis W.A., Van Voorhis B.J.: “Natural history of uterine polyps and leiomyomata”. Obstet. Gynecol., 2002, 100, 3.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top